Cargando…
PSMC2 Regulates Cell Cycle Progression Through the p21/Cyclin D1 Pathway and Predicts a Poor Prognosis in Human Hepatocellular Carcinoma
Proteasome 26S subunit ATPase 2 (PSMC2) plays a pathogenic role in various cancers. However, its function and molecular mechanism in hepatocellular carcinoma (HCC) remain unknown. In this study, tissue microarray (TMA) analysis showed that PSMC2 is highly expressed in HCC tumors and correlates with...
Autores principales: | Liu, Yiwei, Chen, Hairong, Li, Xiangcheng, Zhang, Feng, Kong, Lianbao, Wang, Xuehao, Bai, Jin, Wu, Xiaofeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7952995/ https://www.ncbi.nlm.nih.gov/pubmed/33718159 http://dx.doi.org/10.3389/fonc.2021.607021 |
Ejemplares similares
-
PSMC2/ITGA6 axis plays critical role in the development and progression of hepatocellular carcinoma
por: Duan, Xuhua, et al.
Publicado: (2021) -
High expression of PSMC2 promotes gallbladder cancer through regulation of GNG4 and predicts poor prognosis
por: Zhu, Dawei, et al.
Publicado: (2021) -
FER Regulated by miR-206 Promotes Hepatocellular Carcinoma Progression via NF-κB Signaling
por: Ding, Wenzhou, et al.
Publicado: (2021) -
CD146 promotes metastasis and predicts poor prognosis of hepatocellular carcinoma
por: Jiang, Guoqing, et al.
Publicado: (2016) -
Identification of CFHR4 associated with poor prognosis of hepatocellular carcinoma
por: Ding, Qinglin, et al.
Publicado: (2022)